Companies: 10,795·Total market cap: $144.5T
Celularity Inc.

Celularity Inc.

CELUNASDAQHealthcare● Active
$0.81
$-0.00(-0.24%)
Market Cap$19483213
P/E Ratio—
52W High$4.35
52W Low$0.71
SEC Filings

Celularity Inc. (CELU) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001752828 · CELU · NASDAQ · as of Jun 9, 2026

Filing snapshot

535
Total Filings
8-K
Latest Form
2026-06-03
Most Recent
2019
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001752828 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-04-30
Fiscal Year End
Apr 30, 2026
Accession No.
0001493152-26-020424
Primary Document
form10-k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001752828 · Accession 0001493152-26-020424

Latest Key Filings

10-QQuarterly Report
10-Q
2025-11-14
View 10-Q on SEC
8-KCurrent Report
8-K
2026-06-03Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-06-03
View
8-KCurrent Report
8-K
2026-05-28
View
NT 10-QNT 10-Q
NT 10-Q
2026-05-15
View
10-KAnnual Report
10-K
2026-04-30
View
3Initial Statement of Beneficial Ownership
OWNERSHIP DOCUMENT
2026-04-24
View
3Initial Statement of Beneficial Ownership
OWNERSHIP DOCUMENT
2026-04-24
View
3Initial Statement of Beneficial Ownership
OWNERSHIP DOCUMENT
2026-04-24
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-04-22
View
8-KCurrent Report
8-K
2026-04-21
View
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2026-04-03
View
NT 10-KNT 10-K
NT 10-K
2026-03-31
View
8-KCurrent Report
8-K
2026-03-10
View
8-KCurrent Report
8-K
2026-03-05
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-11
View
8-KCurrent Report
8-K
2026-01-21
View
Showing 1–15 of 387 filingsForm 4 / 144 hidden· 535 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001752828  |  Exchange: NASDAQ · Healthcare

Celularity Inc. (NASDAQ: CELU) has submitted 535 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001752828, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Celularity Inc.'s most comprehensive regulatory disclosure. The most recent Celularity Inc. 10-K was filed on 2026-04-30 for fiscal year ending 2026. Historical CELU 10-K annual reports are available from 2018 through 2026.

Investors researching Celularity Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
KZR SEC Filings →PYPD SEC Filings →FGEN SEC Filings →GBIO SEC Filings →ANVS SEC Filings →BTAI SEC Filings →ATNM SEC Filings →TPST SEC Filings →
→ CELU Financials→ CELU Earnings→ CELU Insider Trades

Frequently Asked Questions

CELU SEC Filings · 8 questions

Celularity Inc. (CELU) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 535 filings and access original documents at no cost. Celularity Inc.'s CIK is 0001752828.

CELU SEC filingsCelularity Inc. SEC documentsfind CELU 10-K